Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy

Susanne Vrtala, Kora Hirtenlehner, Markus Susani, Peter Hufnagl, Bernd R. Binder, Luca Vangelista, Annalisa Pastore, Wolfgang R. Sperr, Peter Valent, Christof Ebner, Dietrich Kraft, Rudolf Valenta

Research output: Contribution to journalArticle

31 Citations (Scopus)
Original languageEnglish
Pages (from-to)218-219
Number of pages2
JournalInternational Archives of Allergy and Immunology
Volume118
Issue number2-4
DOIs
Publication statusPublished - Jan 1 1999

Keywords

  • Bet v 1
  • Birch pollen allergens
  • Hypoallergenic allergens
  • Immunotherapy
  • Recombinant
  • Skin testing
  • Type I allergy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Vrtala, S., Hirtenlehner, K., Susani, M., Hufnagl, P., Binder, B. R., Vangelista, L., Pastore, A., Sperr, W. R., Valent, P., Ebner, C., Kraft, D., & Valenta, R. (1999). Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy. International Archives of Allergy and Immunology, 118(2-4), 218-219. https://doi.org/10.1159/000024075